Colleen Moretti | Authors

Articles

Axi-Cel Outperforms Alternate Treatments in R/R Follicular Lymphoma

June 14, 2021

Axicabtagene ciloleucel improved outcomes for patients with relapsed/refractory follicular lymphoma over currently available therapies, according to data from a comparative analysis of the ZUMA-5 and SCHOLAR-5 trials.